Dr. Jeffrey Bluestone is the CEO and President of Sonoma Biotherapeutics, which is leveraging the properties of regulatory T cells to create living cell therapies that restore the immune system back to its balanced, fully functioning state. He was previously a Professor at the Diabetes Center at the University of California San Francisco, and his research over the past 25 years has focused on understanding the basic processes that control T cell activation and immune tolerance in autoimmunity and organ transplantation.

Image by Steve Babuljak, courtesy of Dr. Jeff Bluestone

Listen to the episode here.